These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32448023)

  • 1. Immediate versus wait-and-gradual discontinuation in antipsychotic switching: A meta-analysis.
    Takeuchi H; Remington G
    J Psychopharmacol; 2020 Aug; 34(8):914-919. PubMed ID: 32448023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate vs Gradual Discontinuation in Antipsychotic Switching: A Systematic Review and Meta-analysis.
    Takeuchi H; Kantor N; Uchida H; Suzuki T; Remington G
    Schizophr Bull; 2017 Jul; 43(4):862-871. PubMed ID: 28044008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gradual vs. wait-and-gradual discontinuation in antipsychotic switching: A meta-analysis.
    Takeuchi H; Thiyanavadivel S; Agid O; Remington G
    Schizophr Res; 2017 Nov; 189():4-8. PubMed ID: 28242107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
    Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G
    J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis.
    Matsui K; Tokumasu T; Takekita Y; Inada K; Kanazawa T; Kishimoto T; Takasu S; Tani H; Tarutani S; Hashimoto N; Yamada H; Yamanouchi Y; Takeuchi H
    Schizophr Res; 2019 Jul; 209():50-57. PubMed ID: 31182319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid vs. slow antipsychotic initiation in schizophrenia: A systematic review and meta-analysis.
    Takeuchi H; Thiyanavadivel S; Agid O; Remington G
    Schizophr Res; 2018 Mar; 193():29-36. PubMed ID: 28844639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic Dose in Acute Schizophrenia: A Meta-analysis.
    Takeuchi H; MacKenzie NE; Samaroo D; Agid O; Remington G; Leucht S
    Schizophr Bull; 2020 Dec; 46(6):1439-1458. PubMed ID: 32415847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pimozide for schizophrenia or related psychoses.
    Mothi M; Sampson S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD001949. PubMed ID: 24194433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).
    Moncrieff J; Lewis G; Freemantle N; Johnson S; Barnes TRE; Morant N; Pinfold V; Hunter R; Kent LJ; Smith R; Darton K; Horne R; Crellin NE; Cooper RE; Marston L; Priebe S
    BMJ Open; 2019 Nov; 9(11):e030912. PubMed ID: 31780589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of strategies for switching patients from olanzapine to risperidone: a randomized, open-label, rater-blinded study.
    Ganguli R; Brar JS; Mahmoud R; Berry SA; Pandina GJ
    BMC Med; 2008 Jun; 6():17. PubMed ID: 18590519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders.
    Andrade C
    J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38767930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials.
    Højlund M; Kemp AF; Haddad PM; Neill JC; Correll CU
    Lancet Psychiatry; 2021 Jun; 8(6):471-486. PubMed ID: 34023019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials.
    Bogers JPAM; Hambarian G; Walburgh Schmidt N; Vermeulen JM; de Haan L
    Schizophr Bull; 2023 Jan; 49(1):11-23. PubMed ID: 36200866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.
    Kinon BJ; Basson BR; Gilmore JA; Malcolm S; Stauffer VL
    J Clin Psychiatry; 2000 Nov; 61(11):833-40. PubMed ID: 11105736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis.
    Sakuma K; Matsunaga S; Nomura I; Okuya M; Kishi T; Iwata N
    Psychopharmacology (Berl); 2018 Aug; 235(8):2303-2314. PubMed ID: 29785555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia.
    Wisniewski CS; Robert S
    Ann Pharmacother; 2012; 46(7-8):1097-104. PubMed ID: 22811346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine versus typical antipsychotic medications for schizophrenia.
    Suttajit S; Srisurapanont M; Xia J; Suttajit S; Maneeton B; Maneeton N
    Cochrane Database Syst Rev; 2013 May; (5):CD007815. PubMed ID: 23728667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Aripiprazole Worsen Psychosis in Schizophrenia? A Meta-Analysis of Double-Blind, Randomized, Controlled Trials.
    Takeuchi H; Fathi A; Thiyanavadivel S; Agid O; Remington G
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29570965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study.
    Casey DE; Carson WH; Saha AR; Liebeskind A; Ali MW; Jody D; Ingenito GG;
    Psychopharmacology (Berl); 2003 Apr; 166(4):391-9. PubMed ID: 12610718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.